Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Capital Work in Progress

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹26 Cr₹21 Cr₹26 Cr₹25 Cr₹25 Cr

What is the latest Capital Work in Progress ratio of VENUS REMEDIES ?

The latest Capital Work in Progress ratio of VENUS REMEDIES is ₹26 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹26 Cr
Mar2024₹21 Cr
Mar2023₹26 Cr
Mar2022₹25 Cr
Mar2021₹25 Cr

How is Capital Work in Progress of VENUS REMEDIES Trending?

Years Capital Work in Progress % Change
Mar2025 ₹26 Cr
25.17
Mar2024 ₹21 Cr
-19.21
Mar2023 ₹26 Cr
3.43
Mar2022 ₹25 Cr
0.49
Mar2021 ₹25 Cr -

Compare Capital Work in Progress of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹900.7 Cr -9.6% -17.9% 121.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-9.6%

-17.9%

121.1%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses